EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer

Yuto Kishimoto, Motoharu Sasaki iD, Hideki Otsuka iD, Akiko Kubo, Chisato Tonoiso, Takashi Kawanaka, Takaharu Kudoh, Hitoshi Ikushima iD

Journal of Radiation Research · 2026

DOI: 10.1093/jrr/rrag060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2026. Verfasst von Yuto Kishimoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Course of Radiological Sciences, Graduate School of Health Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Chemoradiotherapy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is the fourth most common malignancy globally. As many cases are locally advanced, early prediction of local recurrence, which often occurs within 2 years of chemoradiotherapy (CCRT), is crucial. The National Comprehensive Cancer Network Guidelines recommend post-treatment 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for response assessment, but this is not standard in Japan. We aimed to investigate the utility of 18F-FDG-PET/CT in assessing primary tumor response after CCRT for cervical cancer. Seventy-three patients with cervical cancer who received curative CCRT and underwent pre- and post-treatment magnetic resonance imaging and 18F-FDG-PET/CT were analyzed. We collected PET metrics (maximum standardized uptake value [SUVmax], metabolic tumor volume [MTV], total lesion glycolysis [TLG]) and classified the response. Receiver operating characteristic (ROC) curve analysis was performed on the post-treatment PET data. Univariate analysis was performed to determine the prognostic factors for local control. ROC curve analysis yielded high negative predictive values for local recurrence of post-treatment MTV, SUVmax and TLG. Univariate analysis showed significant differences in local control for post-treatment MTV, SUVmax, TLG and PET Response Criteria in Solid Tumors, but not for Response Evaluation Criteria in Solid Tumors (RECIST). Functional assessment using 18F-FDG-PET/CT after CCRT for cervical cancer is useful for complementing conventional morphological evaluation and improving the accuracy of response assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyChemoradiotherapyHumansFemaleTreatment OutcomeMiddle AgedAdultAgedROC CurveRadiopharmaceuticals

Stichwörter der Autor:innen

18F-FDG-PET/CTPERCISTradiotherapyuterine cervical cancer

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Course of Radiological Sciences, Graduate School of Health Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
  • Department of Therapeutic Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
  • Department of Medical Imaging/Nuclear Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
  • Department of Radiology and Radiation Oncology, Institute of Biomedical Sciences, Graduate School, Tokushima University Tokushima, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
  • Department of Radiation Oncology, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan.
  • Department of Oral Surgery, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504, Japan.

ORCID-Profile: Motoharu Sasaki, Hideki Otsuka, Hitoshi Ikushima

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kishimoto, Y., Sasaki, M., Otsuka, H., Kubo, A., Tonoiso, C., Kawanaka, T., Kudoh, T., & Ikushima, H. (2026). Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrag060

Vancouver

Kishimoto Y, Sasaki M, Otsuka H, Kubo A, Tonoiso C, Kawanaka T, et al. Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer. Journal of Radiation Research. 2026. doi:10.1093/jrr/rrag060

BibTeX
@article{Kishimoto2026,
  author = {Kishimoto, Yuto and Sasaki, Motoharu and Otsuka, Hideki and Kubo, Akiko and Tonoiso, Chisato and Kawanaka, Takashi and Kudoh, Takaharu and Ikushima, Hitoshi},
  title = {Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer},
  journal = {Journal of Radiation Research},
  year = {2026},
  doi = {10.1093/jrr/rrag060}
}
Kostenlos starten →